Suppr超能文献

移植患者在接受免疫抑制治疗下进行局部区域胸部放化疗后发生致命性双侧放射性肺炎。

Fatal bilateral pneumonitis after locoregional thoracic chemoradiation in a transplanted patient under immunosuppressive therapy.

机构信息

Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands

Department of Radiation Oncology, University Hospitals Leuven/KU Leuven, Leuven, Belgium.

出版信息

Anticancer Res. 2014 Dec;34(12):7315-7.

Abstract

BACKGROUND

After thoracic radiotherapy a pneumonitis may occur, mostly confined to the irradiated volume of the lung. In general, it resolves spontaneously without long-term effects.

CASE REPORT

A 68-year-old man was diagnosed with a stage IIIA adenocarcinoma of the lung and was treated with sequential chemoradiation. He had a heart and kidney transplant for which an immunosuppressant was taken. During the fourth week of radiotherapy, he developed a bilateral interstitial pneumonia. Despite antibiotics and steroids, the patient died twelve days after the onset of complaints due to respiratory failure. Autopsy showed in all pulmonary lobes extensive diffuse alveolar damage, probably leading to respiratory insufficiency and death. Literature and Conclusion: Bilateral pneumonitis after radiotherapy is thought to be an immunologically-mediated response, which usually resolves without long-term effects. Since in radiation pneumonitis an increase in T-cells is described, the suppression of these cells by an immunosuppressant might have exaggerated the pulmonary toxicity.

摘要

背景

胸部放疗后可能会发生放射性肺炎,通常局限于肺部受照射的区域。一般情况下,它会自行消退,不会产生长期影响。

病例报告

一名 68 岁男性被诊断为 IIIA 期肺腺癌,接受了序贯放化疗。他曾因心脏和肾脏移植而服用免疫抑制剂。在放疗的第四周,他出现双侧间质性肺炎。尽管使用了抗生素和类固醇,但在出现症状后的第十二天,患者因呼吸衰竭而死亡。尸检显示所有肺叶均有广泛的弥漫性肺泡损伤,可能导致呼吸功能不全和死亡。

文献和结论

放疗后出现双侧肺炎被认为是一种免疫介导的反应,通常不会产生长期影响。由于放射性肺炎中描述了 T 细胞的增加,免疫抑制剂对这些细胞的抑制可能加重了肺部的毒性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验